Prior Investments - Biotechnology |
||
| Biotechnology | Communications & Networking | Consumer Related | ||
| Internet | Medical Devices | Software | Other Technology | Other Life Sciences | ||
Prior to HTGC, we originated or approved over $2.5 billion of investments |
||
to technology and life sciences companies. |
||
| 3-D Pharmaceuticals Acusphere, Inc. Amylin Anergen Archemix Aureon BioSciences Auxilium Pharmaceuticals BioMarin Centagenetix Ciphergen Biosystems CombiChem CombinatoRx Compound Therapeutics Coral Therapeutics, Inc Corgentech Corixa Cotherix Curis, Inc. |
Cytel Cytokinetics Discovery Partners Elitra Pharmaceuticals, Inc. Entelos, Inc. Eunoe Ferx Incorporated Fluidigm GenPath Gentiae GenVec Human Genome Sciences IDUN Pharmaceuticals Isis Pharmaceuticals LeukoSite KAI Pharmaceuticals Magainin Pharmaceuticals Medicines Company |
Microcide Pharmaceuticals Miikana Millennium Neurex NuGen Technology Orchid BioSciences Pharmacyclics Scion Sequana Therapeutics Sequenom Sphinx Pharmaceuticals Telios Pharmaceuticals Transform Pharmaceuticals Trellis Bioscience Tularik Variagenics Vaxinnate Xenoport, Inc. |